ORBIMED ADVISORS LLC Compass Therapeutics, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$50.07M
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

-13.96%
quarter

Compass Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -8.12M $2.28 21.96M
Q2 2022 share Increase +1.47% 317.87K shares 28.54M $2.65 21.96M
Q1 2022 share 0.00% 0 shares -38.95M $1.37 21.64M
Q4 2021 share Increase 0.00% 21.64M shares 68.60M $3 21.64M